SCHEMBL2535519

SCHEMBL2535519

COC(=O)c1ccc2c(c1)CC(C)(C)C(c1ccc(F)c(NC(=O)c3ccccc3)c1)N2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 6/20 0.47
HDAC1 Q13547 2/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
RAB9A P51151 2/20 0.39
PPARG P37231 1/20 0.38
NR1H4 Q96RI1 1/20 0.38
KMT2A Q03164 2/20 0.38
CYP1A2 P05177 2/20 0.38
F2 P00734 1/20 0.38
CYP2C9 P11712 1/20 0.38
HPGD P15428 1/20 0.38
MEN1 O00255 1/20 0.38
ROCK2 O75116 1/20 0.37
NPC1 O15118 1/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.37
CYP2C19 P33261 1/20 0.37
KDM4E B2RXH2 1/20 0.36
MAPK1 P28482 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2533068 0.92 PPARG (0.46) MAPK14HDAC1HDAC8HDAC6RAB9A
SCHEMBL2527678 0.89 GRM4 (0.39) MAPK14RAB9AKMT2AMEN1ROCK2
SCHEMBL15509849 0.87 MAPK14 (0.41) MAPK14HDAC1HDAC8HDAC6RAB9A
SCHEMBL2532967 0.86 ALDH1A1 (0.43) MAPK14RAB9AKMT2AHPGDMEN1
SCHEMBL2536690 0.86 ALDH1A1 (0.46) MAPK14RAB9AKMT2ACYP1A2HPGD
SCHEMBL2535710 0.86 PTPN1 (0.49) RAB9AKMT2ACYP1A2F2CYP2C9
SCHEMBL2534017 0.85 ALDH1A1 (0.42) MAPK14RAB9AKMT2ACYP1A2HPGD
SCHEMBL2527848 0.85 ALDH1A1 (0.42) MAPK14RAB9AKMT2ACYP1A2HPGD
SCHEMBL2529541 0.85 WDR5 (0.39) RAB9AKMT2AHPGDMEN1NPC1
SCHEMBL2532196 0.84 ALDH1A1 (0.41) MAPK14HDAC1RAB9AKMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2558449-B1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HOFFMANN LA ROCHE (CH) 2014-03-05 EP disclosed
US-8586747-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2013-11-19 US disclosed
EP-2558449-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2013-02-20 EP disclosed
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES Hoffmann-La Roche Inc (US) 2013-01-24 US disclosed
US-8344137-B2 3,3-dimethyl tetrahydroquinoline derivatives HOFFMAN-LA ROCHE INC. (US) 2013-01-01 US disclosed
WO-2011128251-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2011-10-20 WO disclosed
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES HUA MEDICINE (KY) 2011-10-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110257151-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 MAPK14 1857/4885HDAC1 244/4885HDAC8 1881/4885
US-20130023518-A1 NOVEL 3,3-DIMETHYL TETRAHYDROQUINOLINE DERIVATIVES QDPR, PRMT3, PRMT1 MAPK14 1857/4885HDAC1 244/4885HDAC8 1881/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.